TestoPlex Plus By XYMOGEN Overview & Drug Interactions

Check For Interactions With TestoPlex Plus

Supplement: TestoPlex Plus by XYMOGEN

TestoPlex Plus Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with TestoPlex Plus by XYMOGEN

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
2 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container 60
UPC/BARCODE 871149002121

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
PrimaVie Shilajit
500 mg
Shilajit --
LJ100 Eurycoma longifolia extract
200 mg
Eurycoma Longifolia --

Other Ingredients:
Capsule
Forms
  • Hypromellose
  • Water
Microcrystalline Cellulose
Dicalcium Phosphate
Ascorbyl Palmitate
Silica


Label Statments:


General Statements
- Professional use only Not for sale on third-party websites, including, but not limited to, Amazon and eBay.
- TestoPlex Plus features two safe, clinically-tested, standardized, and patented ingredients designed to support vitality and general physical and mental well-being in men and women.
- Supports vitality, virility, and vigor
- Exclusive professional formulas
- Scan to learn more! This package is completely recyclable
Suggested/Recommended/Usage/Directions
- Directions: Take two capsules in the morning, or as directed by your healthcare practitioner.
Precautions
- Consult your healthcare practitioner prior to use.
- Individuals taking medication should discuss potential interactions with their healthcare practitioner.
- Do not use if tamper seal is damaged. The labeling on this product does not comply with California's Proposition 65. Therefore, this product may not be sold in California.
- Storage: Keep closed in a cool, dry place out of reach of children.
Formula
- Numerous studies have demonstrated that PrimaVie shilajit and LJ100 Eurycoma longifolia support healthy androgen biosynthesis, which includes modulating the influence of sex hormone-binding globulin.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Storage
- Storage: Keep closed in a cool, dry place out of reach of children.
Formulation
- Does not contain: Wheat, gluten, corn, yeast, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.
- Vegetarian Caps
Seals/Symbols
- ePV
- Vegetarian caps
- Third-Party GMP Compliant Verified
FDA Statement of Identity
- Dietary Supplement
Brand IP Statement(s)
- PrimaVie is protected under US patents 6,969,612 and 6,440,712 and is a trademark of Natreon, Inc. LJ100 is the registered trademark of HP Ingredients. Worldside patent WO/02/17946 Bioactive Fraction of Eurycoma Longifolia. US patent 7,132,117 Bioactive Fraction of Eurycoma Longifolia.
- 2018 XYMOGEN

Brand Information

See all products by this brand

Manufacturer
Name XYMOGEN Exclusive Professional Formulas
Street Address 6900 Kingspointe Pkwy.
City Orlando
State FL
ZipCode 32819
Phone Number 800-647-6100
Web Address www.xymogen.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.